APA (7th ed.) Citation

L, B., MM, G., & JC, T. (2021). ASO Author Reflections: Objective Response Rate after Short Duration (< 9 Weeks) Is Not Inferior to Moderate (9-27 Weeks) or Long Duration (> 27 Weeks) of Neoadjuvant Endocrine Therapy (NET)-An NCDB Analysis. Annals of surgical oncology, 28(13), 8663. https://doi.org/10.1245/s10434-021-10517-w

Chicago Style (17th ed.) Citation

L, Burkbauer, Goldbach MM, and Tchou JC. "ASO Author Reflections: Objective Response Rate After Short Duration (< 9 Weeks) Is Not Inferior to Moderate (9-27 Weeks) or Long Duration (> 27 Weeks) of Neoadjuvant Endocrine Therapy (NET)-An NCDB Analysis." Annals of Surgical Oncology 28, no. 13 (2021): 8663. https://doi.org/10.1245/s10434-021-10517-w.

MLA (9th ed.) Citation

L, Burkbauer, et al. "ASO Author Reflections: Objective Response Rate After Short Duration (< 9 Weeks) Is Not Inferior to Moderate (9-27 Weeks) or Long Duration (> 27 Weeks) of Neoadjuvant Endocrine Therapy (NET)-An NCDB Analysis." Annals of Surgical Oncology, vol. 28, no. 13, 2021, p. 8663, https://doi.org/10.1245/s10434-021-10517-w.